HIV

Pharmacokinetic Assessment Shows Value in HIV

Pharmacokinetic Assessment Shows Value in HIV

By

Pharmacokinetic assessment is a major component in choosing route of admission with antiretroviral agents for HIV infection.

Early ART Initiation May Increase Bone Loss in Patients With HIV

Early ART Initiation May Increase Bone Loss in Patients With HIV

By

Early antiretroviral therapy initiation may increase the rate of bone loss in HIV patients.

Amphotericin B Better Than Itraconazole in HIV-Linked Talaromycosis

Amphotericin B Better Than Itraconazole in HIV-Linked Talaromycosis

By

Treatment with antifungal drug amphotericin B is superior to itraconazole for HIV-associated talaromycosis.

 Does ART Increase Risk of Diabetes in HIV-infected Patients?

Does ART Increase Risk of Diabetes in HIV-infected Patients?

By

Antiretroviral therapy may be the most consistent determinant of diabetes in patients with HIV.

HIV Testing Insufficient in Young MSM

HIV Testing Insufficient in Young MSM

A new study finds that not enough young MSM receive HIV testing despite accounting for most new diagnosis.

Financial Incentives Offer Promise in Improving HIV Viral Suppression

Financial Incentives Offer Promise in Improving HIV Viral Suppression

Financial incentives increase viral suppression in HIV-positive patients.

Reduced Corneal Nerve Fiber Density in HIV-associated Sensory Neuropathy

Reduced Corneal Nerve Fiber Density in HIV-associated Sensory Neuropathy

Patients with HIV and HIV-associated sensory neuropathy (HIV-SN) have reduced corneal nerve fiber density.

Vaginal Microbiome May Render HIV Tenofovir Microbicide Less Effective

Vaginal Microbiome May Render HIV Tenofovir Microbicide Less Effective

By

Tenofovir gel reduced the incidence of HIV infection by 61% in women with Lactobacillus-dominant vaginal flora but only 18% in women with non-Lactobacillus bacteria, according to a new study.

Advanced Disease, Mental Comorbidity Affect QoL Among Military HIV Patients

Advanced Disease, Mental Comorbidity Affect QoL Among Military HIV Patients

By

Researchers determined the factors affecting health-related quality of life in military HIV patients.

Reducing Risk of HIV Transmission in HIV-Discordant Couples

Reducing Risk of HIV Transmission in HIV-Discordant Couples

New methods are available for reducing the risk of HIV transmission in HIV-discordant couples who would like to attempt conception.

Women With HIV Have Higher Cervical Cancer Progression

Women With HIV Have Higher Cervical Cancer Progression

By

Women with HIV are more likely to experience progressive cervical changes.

HCV Cure Rates High in HIV Coinfection With Integrated Healthcare Program

HCV Cure Rates High in HIV Coinfection With Integrated Healthcare Program

For patients with HCV and HIV coinfection, treatment is effective with standardized nurse/pharmacist support at urban clinics.

Gilead Submits NDA for Triple-Therapy, Single Tablet HIV Regimen

Gilead Submits NDA for Triple-Therapy, Single Tablet HIV Regimen

By

Gilead submitted their single-tablet regimen containing bictegravir, emtricitabine, and tenofovir alafenamide for HIV-1 treatment to the FDA.

FDA Approves New Labeling Updates for Prezcobix

FDA Approves New Labeling Updates for Prezcobix

By

The Food and Drug Administration has approved labeling updates for Prezcobix tablets for HIV.

Advanced HIV Trends at ART Initiation in 10-High-Burden Countries

Advanced HIV Trends at ART Initiation in 10-High-Burden Countries

Decreases were found in the prevalence of advanced disease at initiation of antiretroviral therapy (ART) in 10 high-burden countries.

FDA Approves New Dosing Option for Raltegravir in Treating HIV-1

FDA Approves New Dosing Option for Raltegravir in Treating HIV-1

By

The FDA approved higher dose of Isentress for the treatment of HIV-1 infection in adults and pediatric patients.

Last Gift Study: A Participant's Perspective on End-of-Life HIV Research

Last Gift Study: A Participant's Perspective on End-of-Life HIV Research

By

Dr Sara Gianella Weibel talks with Anthony B, a patient with HIV and end-stage amyotrophic lateral sclerosis and the first participant enrolled in the "Last Gift" end-of-life study, about his experience as part of this new end-of-life model to study HIV persistence.

Last Gift Study: Community Perspective on End-of-Life HIV Research

Last Gift Study: Community Perspective on End-of-Life HIV Research

By

Dr Sara Gianella Weibel talks with Jeff Taylor, community activist and long-term HIV survivor, about a new end-of-life model to study HIV persistence.

FDA: New Oral Powder Formulation Approved for HIV Treatment

FDA: New Oral Powder Formulation Approved for HIV Treatment

By

Norvir, an oral powder formulation to treat HIV-1 patients, has been approved by the FDA.

Last Gift Study: End-of-Life HIV Research

Last Gift Study: End-of-Life HIV Research

By

Dr Sara Gianella Weibel talks with Dr Davey Smith, head of the Division of Infectious Disease at the University of California, San Diego, about a proposed new model to study HIV persistence, called the Last Gift study.

Risk of Virus-Associated Cancers in HIV-uninfected MSM With Nitrite Inhalants

Risk of Virus-Associated Cancers in HIV-uninfected MSM With Nitrite Inhalants

By

Long-term heavy nitrite inhalant use is associated with elevated risk of some virus-associated cancers.

Adherence to Antiretroviral Therapy Increased From 2001 to 2010

Adherence to Antiretroviral Therapy Increased From 2001 to 2010

More Americans with HIV are adhering to antiretroviral therapy regimens.

First Generic Truvada Approved for HIV Infection and PrEP

First Generic Truvada Approved for HIV Infection and PrEP

By

The FDA has approved the first generic version of Gilead's Truvada 200mg/300mg.

Novel RNA Virus Detected With Next-Generation Metagenomic Sequencing

Novel RNA Virus Detected With Next-Generation Metagenomic Sequencing

Next-generation metagenomic sequencing can detect a new RNA virus, human hepegivirus-1.

Postpartum ART Safe, Beneficial in HIV-Positive Women

Postpartum ART Safe, Beneficial in HIV-Positive Women

By

Antiretroviral therapy was found to be safe and clinically beneficial in young, postpartum women with high CD4+ T cell counts.

 HIV Testing: Does Home-Based Self-Testing Increase Rates?

HIV Testing: Does Home-Based Self-Testing Increase Rates?

By

Free home-based HIV self-testing does not result in higher rates of testing.

Treating Insulin Resistance in HIV Patients With Lipodystrophy

Treating Insulin Resistance in HIV Patients With Lipodystrophy

By

Liver damage in patients with HIV and abdominal fat is linked to insulin resistance.

 Is Ending the HIV/AIDS Epidemic in the US Feasible by 2025?

Is Ending the HIV/AIDS Epidemic in the US Feasible by 2025?

By

Researchers at Johns Hopkins were able to project yearly estimates of new HIV infections and forecast the route of HIV in the US.

HIV RNA Replication in Semen Occurs During Antiretroviral Therapy

HIV RNA Replication in Semen Occurs During Antiretroviral Therapy

By

Study looks at the decay of HIV viral load in the genital tract by comparing the effect of different drug families on treatment-naive HIV-infected patients.

Outcomes of an HIV Transmission Prevention Program in Southern Africa

Outcomes of an HIV Transmission Prevention Program in Southern Africa

By

Preventing the transmission of human immunodeficiency virus (HIV) is central to controlling the HIV epidemic in southern Africa. The PopART intervention program aimed to achieve high rates of universal testing and treatment using community-based health workers to conduct home visits in which they provided services such as HIV testing and referral to ART care.

Sign Up for Free e-newsletters